XML 35 R19.htm IDEA: XBRL DOCUMENT v3.22.1
SHARE-BASED COMPENSATION
 12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION SHARE-BASED COMPENSATION
Restricted Stock

We issued equity-based awards from the 2016 Omnibus Plan.

2016 Omnibus Incentive Plan

On June 19, 2019, our shareholders approved an amendment to the DXP Enterprises, Inc. 2016 Omnibus Incentive Plan (the “2016 Plan”) to increase the number of shares that can be issued under the 2016 Plan from 500,000 shares to a total of 1,000,000 shares, which represents an increase of 500,000 shares (the “Amendment”), which authorized grants of restricted stock awards, restricted stock units (“RSUs”), performance awards, options, investment rights, and cash-based awards. This plan authorizes the issuance of up to 1,000,000 shares of our common stock.
Under the 2016 Omnibus Plan approved by our shareholders, directors, consultants and employees may be awarded shares of DXP’s common stock. The shares of restricted stock awards granted to employees that are outstanding as of December 31, 2021 vest in accordance with one of the following vesting schedules: 100% one year after the grant date; 50% each year for two years after the grant; 33.3% each year for three years after the grant date; 20% each year for five years after the grant date; or 10% each year for ten years after the date of grant. The shares of restricted stock awards granted to non-employee directors of DXP vest one year after the grant date. The fair value of restricted stock awards is measured based upon the closing prices of DXP’s common stock on the grant dates and is recognized as compensation expense over the vesting period of the awards. Once restricted stock vests, new shares of the Company’s stock are issued. At December 31, 2021, 559,024 shares were available for future grant.

Changes in restricted stock awards for the twelve months ended December 31, 2021 were as follows:
 Number of
Shares		Weighted Average
Grant Price
Non-vested at December 31, 2020166,976 $32.53 
Granted53,668 $30.95 
Forfeited— $— 
Vested(108,600)$32.59 
Non-vested at December 31, 2021112,044 $31.72 
Changes in restricted stock awards for the twelve months ended December 31, 2020 were as follows:
 Number of
Shares		Weighted Average
Grant Price
Non-vested at December 31, 2019144,250 $32.71 
Granted100,299 $30.91 
Forfeited(16,794)$28.61 
Vested(60,779)$31.33 
Non-vested at December 31, 2020166,976 $32.53 
Changes in restricted stock awards for the twelve months ended December 31, 2019 were as follows:
 Number of
Shares		Weighted Average
Grant Price
Non-vested at December 31, 2018169,293 $31.05 
Granted46,885 $35.60 
Forfeited(5,720)$32.35 
Vested(66,208)$27.75 
Non-vested at December 31, 2019144,250 $32.71 
Compensation expense, associated with restricted stock awards, recognized in the years ended December 31, 2021, December 31, 2020 and December 31, 2019 was $1.8 million, $3.5 million, and $2.0 million, respectively. Related income tax benefits recognized in earnings in the years ended December 31, 2021, December 31, 2020 and December 31, 2019 were approximately $0.5 million, $0.9 million and $0.5 million, respectively. Unrecognized compensation expense under the DXP Enterprises, Inc. 2016 Omnibus Plan at December 31, 2021, December 31, 2020 and December 31, 2019 was $2.1 million, $2.2 million and $3.0 million, respectively. As of December 31, 2021, the weighted average period over which the unrecognized compensation expense is expected to be recognized is 1.2 years.